Prenatal screening for Down syndrome in Australia: Costs and benefits of current and novel screening strategies
Tóm tắt
Từ khóa
Tài liệu tham khảo
O'Leary, 2006, First trimester combined screening for Down syndrome and other fetal anomalies in Western Australia, Obstet Gynecol, 107, 869, 10.1097/01.AOG.0000207562.09858.16
Maxwell, 2011, Socio-demographic disparities in the uptake of prenatal screening in Western Australia, Aust N Z J Obstet Gynaecol, 51, 9, 10.1111/j.1479-828X.2010.01250.x
Reid, 1999, Pregnancy loss rates following second trimester genetic amniocentesis, Aust N Z J Obstet Gynaecol, 39, 281, 10.1111/j.1479-828X.1999.tb03397.x
Jaques, 2010, Uptake of prenatal diagnostic testing and the effectiveness of prenatal screening for Down syndrome, Prenat Diagn, 30, 522, 10.1002/pd.2509
Bianchi, 2012, MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group: Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing, Obstet Gynecol, 119, 890, 10.1097/AOG.0b013e31824fb482
Palomaki, 2011, DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study, Genet Med, 13, 913, 10.1097/GIM.0b013e3182368a0e
Palomaki, 2012, DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An international collaborative study, Genet Med, 14, 296, 10.1038/gim.2011.73
Ashoor, 2012, Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18, Am J Obstet Gynecol, 206, e1, 10.1016/j.ajog.2012.01.029
Norton, 2012, Non-invasive chromosomal evaluation (NICE) study: Results of a multicenter, prospective, cohort study for detection of fetal trisomy 21 and trisomy 18, Am J Obstet Gynecol, 207, e1, 10.1016/j.ajog.2012.05.021
Bianchi, 2012, From prenatal genomic diagnosis to fetal personalized medicine: Progress and challenges, Nat Med, 18, 1041, 10.1038/nm.2829
Chiu, 2008, Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma, Proc Natl Acad Sci USA, 105, 20458, 10.1073/pnas.0810641105
Liang, 2013, Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing, Prenat Diagn, 33, 409, 10.1002/pd.4033
Ashoor, 2013, Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method, Ultrasound Obstet Gynecol, 41, 21, 10.1002/uog.12299
Chen, 2011, Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing, PLoS ONE, 6, e21791, 10.1371/journal.pone.0021791
Chiu, 2011, Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study, BMJ, 342, C7401, 10.1136/bmj.c7401
Dan, 2012, Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors, Prenat Diagn, 32, 1225, 10.1002/pd.4002
Ehrich, 2011, Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting, Am J Obstet Gynecol, 204, e1, 10.1016/j.ajog.2010.12.060
Jiang, 2012, Noninvasive fetal trisomy (nifty) test: An advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies, BMC Med Genomics, 5, 57, 10.1186/1755-8794-5-57
Nicolaides, 2012, Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population, Am J Obstet Gynecol, 207, 374, 10.1016/j.ajog.2012.08.033
Nicolaides, 2013, Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, x, and y, Prenat Diagn, 33, 575, 10.1002/pd.4103
Sehnert, 2011, Optimal detection of fetal chromosomal abnormalities by massively parallel sequencing of cell-free fetal DNA from maternal blood, Clin Chem, 57, 1042, 10.1373/clinchem.2011.165910
Sparks, 2012, Non-invasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: Evaluation for trisomy 21 and trisomy 18, Am J Obstet Gynecol, 206, e1, 10.1016/j.ajog.2012.01.030
Zimmermann, 2012, Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci, Prenat Diagn, 32, 1233, 10.1002/pd.3993
American College of Obstetricians and Gynecologists Committee on Genetics and the Society for the Maternal Fetal Medicine Publications Committee Noninvasive prenatal testing for fetal aneuploidy Http://www.Acog.Org/resources_and_publications/committee_opinions/committee_on_genetics/noninvasive_prenatal_testing_for_fetal_aneuploidy
Benn P Borell A Chiu R et al Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis April 2013 http://ispdhomeorg/public/news/2013/PositionStatementAneuploidy4apr2013pdf
Chilberg M Sequenom: Diagnostic testing drives investment thesis May 15, 2012 http://seekingalpha.Com/instablog/400846-marty-chilberg/623241-sequenom-diagnostic-testing-drives-investment-thesis
Timmerman L Verinata's big day arrives, with prenatal Down syndrome test debut xconomy http://www.Xconomy.Com/san-francisco/2012/02/29/verinatas-big-day-arrives-with-prenatal-down-syndrome-test-debut/
Walsh, 2013, Fetal aneuploidy detection by maternal plasma DNA sequencing: A technology assessment, Prenat Diagn, 33, 514, 10.1002/pd.4109
Ball, 2007, First Second Trimester Evaluation of Risk (FASTER) Research Consortium: First-, second-trimester evaluation of risk of Down syndrome, Obstet Gynecol, 110, 10, 10.1097/01.AOG.0000263470.89007.e3
Gekas, 2009, Comparison of different strategies in prenatal screening for Down's syndrome: Cost effectiveness analysis of computer simulation, BMJ, 338, b138, 10.1136/bmj.b138
Song, 2013, Clinical utility and cost of non-invasive prenatal testing with cfdna analysis in high risk women based on a U.S Population, J Matern Fetal Neonatal Med, 26, 1180, 10.3109/14767058.2013.770464
Zimmermann, 2005, Increasing the iodine concentration in the Swiss iodized salt program markedly improved iodine status in pregnant women and children: A 5-y prospective national study, Am J Clin Nutr, 82, 388, 10.1093/ajcn/82.2.388
Australian Government Department of Health and Aging Medicare Benefits Schedule 2013 http://www.Health.Gov.Au/internet/mbsonline/publishing.Nsf/content/medicare-benefits-schedule-mbs-1
Australian Taxation Office Foreign currency equivalent to $1 Aust -1 July 2012 to 30 June 2013 http://www.ato.gov.au/Tax-professionals/TP/1-July-2012-to-30-June-2013/
Mujezinovic, 2007, Procedure-related complications of amniocentesis and chorionic villous sampling: A systematic review, Obstet Gynecol, 110, 687, 10.1097/01.AOG.0000278820.54029.e3
Garfield, 2012, Clinical and cost consequences of incorporating a novel non-invasive prenatal test into the diagnostic pathway for fetal trisomies, J Manag Care Med, 15, 34
O'Leary, 2006, Regional variations in prenatal screening across Australia: Stepping towards a national policy framework, Aust N Z J Obstet Gynaecol, 46, 427, 10.1111/j.1479-828X.2006.00629.x
NIB the costs of having a baby in the private system http://www.Nib.Com.Au/home/documents/having_a_baby_cost_guide.Pdf
Macintosh, 1996, Correction: The selective miscarriage of Down's syndrome from 10 weeks of pregnancy, Br J Obstet Gynaecol, 103, 1172, 10.1111/j.1471-0528.1996.tb09609.x
Susman, 2010, Using population-based data to predict the impact of introducing noninvasive prenatal diagnosis for Down syndrome, Genet Med, 12, 298, 10.1097/GIM.0b013e3181d5d022
Hill, 2012, Women's and health professionals' preferences for prenatal tests for Down syndrome: A discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests, Genet Med, 14, 905, 10.1038/gim.2012.68
Rowe, 2006, Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the multidimensional measure of informed choice, Aust N Z J Obstet Gynaecol, 46, 433, 10.1111/j.1479-828X.2006.00630.x
Spencer, 2002, A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β-hCG and PAPP-A, Prenat Diagn, 22, 887